Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor M Miotto, L Di Rienzo, G Gosti, L Bo’, G Parisi, R Piacentini, A Boffi, ... Communications biology 5 (1), 20221, 2022 | 27 | 2022 |
Lactoferrin inhibition of the complex formation between ACE2 receptor and SARS CoV-2 recognition binding domain R Piacentini, L Centi, M Miotto, E Milanetti, L Di Rienzo, M Pitea, P Piazza, ... International journal of molecular sciences 23 (10), 5436, 2022 | 21 | 2022 |
Hydrophobicity‐enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells A Incocciati, J Kubeš, R Piacentini, C Cappelletti, S Botta, L Bertuccini, ... Protein Science 32 (12), e4819, 2023 | 10 | 2023 |
Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex S Spizzichino, D Boi, G Boumis, R Lucchi, FR Liberati, D Capelli, ... The FEBS Journal 289 (6), 1625-1649, 2022 | 10 | 2022 |
Design of protein-binding peptides with controlled binding affinity: the case of SARS-CoV-2 receptor binding domain and angiotensin-converting enzyme 2 derived peptides G Parisi, R Piacentini, A Incocciati, A Bonamore, A Macone, J Rupert, ... Frontiers in Molecular Biosciences 10, 1332359, 2024 | 6 | 2024 |
Lactoferrins in their interactions with molecular targets: a structure-based overview R Piacentini, A Boffi, E Milanetti Pharmaceuticals 17 (3), 398, 2024 | 4 | 2024 |
Ferritin‐based disruptor nanoparticles: A novel strategy to enhance LDL cholesterol clearance via multivalent inhibition of PCSK9–LDL receptor interaction A Incocciati, C Cappelletti, S Masciarelli, F Liccardo, R Piacentini, A Giorgi, ... Protein Science 33 (9), e5111, 2024 | 3 | 2024 |
Challenges in exploiting human H ferritin nanoparticles for drug delivery: navigating physiological constraints A Macone, C Cappelletti, A Incocciati, R Piacentini, S Botta, A Boffi, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 16 (6 …, 2024 | 1 | 2024 |
Engineered Ferritin with Eu3+ as a Bright Nanovector: A Photoluminescence Study L Affatigato, A Sciortino, G Sancataldo, A Incocciati, R Piacentini, ... Photochemistry and Photobiology 99 (5), 1218-1224, 2023 | 1 | 2023 |
Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism B Taciak, M Bialasek, M Kubiak, I Marszalek, M Gorczak, O Osadchuk, ... Nature Communications 16 (1), 1327, 2025 | | 2025 |
Exploring the NANOG-TET2 interaction interface. Effects of a selected mutation and hypothesis on the clinical correlation with anemias C Testi, R Piacentini, A Perrone, C Bartoli, D Leso, D Pavia, E Pistolesi, ... Frontiers in Chemical Biology 3, 1517163, 2025 | | 2025 |
Macromolecular interactions in solution-Interferometric and turbidimetric studies R Piacentini Università degli Studi di Roma" La Sapienza", 2023 | | 2023 |